Lexaria Bioscience
LEXX
Lexaria Bioscience (LEXX) earnings history
Most recent quarter
- Fiscal period
- Q3 2025
- Period end
- May 31, 2025
- EPS actual
- −$3.15
- EPS estimate
- −$2.18
- EPS surprise
- −44.83%
- Revenue surprise
- +27.01%
- Revenue
- $174,000.00
- Revenue estimate
- $137,000.00
- Reported
- Jul 14, 2025
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q3 2025 | Jul 14, 2025 | −$2.18 | −$3.15 | −44.83% | $174,000.00 | SEC |
| Q2 2025 | Apr 14, 2025 | −$2.45 | −$2.25 | +8.16% | $174,000.00 | SEC |
| Q1 2025 | Jan 10, 2025 | −$1.80 | −$2.40 | −33.33% | $184,000.00 | SEC |
| Q4 2024 | Nov 26, 2024 | −$1.80 | −$2.10 | −16.67% | $92,000.00 | SEC |
| Q3 2024 | Jul 12, 2024 | −$1.95 | −$1.95 | +0.00% | $0.00 | SEC |
| Q2 2024 | Apr 9, 2024 | −$1.50 | −$0.90 | +40.00% | $145,000.00 | SEC |
| Q1 2024 | Jan 12, 2024 | −$1.65 | −$1.95 | −18.18% | $151,000.00 | SEC |
| Q3 2023 | Jul 14, 2023 | −$3.75 | −$5.55 | −48.00% | $93,000.00 | SEC |
| Q2 2023 | Apr 14, 2023 | $0.00 | −$3.30 | +0.00% | $0.00 | SEC |
| Q1 2023 | Jan 17, 2023 | $0.00 | −$4.50 | +0.00% | $101,476.00 | SEC |
| Q3 2022 | Jul 14, 2022 | −$4.20 | −$6.15 | −46.43% | $100,000.00 | — |
| Q2 2022 | Apr 11, 2022 | −$3.15 | −$3.75 | −19.05% | $30,650.00 | — |
| Q1 2022 | Jan 14, 2022 | $0.00 | −$5.25 | +0.00% | $13,880.00 | — |
| Q3 2021 | Jul 15, 2021 | $0.00 | −$7.50 | +0.00% | $204,000.00 | — |
Quarterly revenue
Frequently asked questions
When did Lexaria Bioscience (LEXX) last report earnings?
Lexaria Bioscience last reported on Jul 14, 2025, covering fiscal Q3 2025.
Did LEXX beat earnings estimates?
No. Lexaria Bioscience reported EPS of −$3.15 for Q3 2025 against a −$2.18 estimate — a 44.83% miss.
How much revenue did LEXX report last quarter?
Lexaria Bioscience reported $174,000.00 in revenue for Q3 2025, against a consensus estimate of $137,000.00.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.